Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.

• Status: Completed
• Trial end date: 2010-11-01

Summary

The purpose of this study is to compare the antihypertensive effect of azilsartan medoxomil plus chlorthalidone, once daily (QD), to olmesartan medoxomil plus hydrochlorothiazide in participants with moderate to severe hypertension.

• Phase: Phase 3

Details

• Lead Sponsor: Takeda
• Treatments: Azilsartan medoxomil; Chlorthalidone; Hydrochlorothiazide; Olmesartan; Olmesartan Medoxomil